NCT02883049 2026-06-02Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsNational Cancer Institute (NCI)Phase 3 Completed5,949 enrolled 28 charts